HUTCHMED (China) (HCM) Non Operating Interest Expenses (2015 - 2020)
HUTCHMED (China) (HCM) posted quarterly Non Operating Interest Expenses of -$3000.0 for Q1 2020, up 96.55% quarter-over-quarter from -$87000.0 in Q2 2016.
HUTCHMED (China) (HCM) Non Operating Interest Expenses (2015 - 2020) Analysis & Trends
HUTCHMED (China) (HCM) has reported Non Operating Interest Expenses for 3 consecutive years, with -$3000.0 the latest figure, recorded in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -3,000.00 |
| Jun 30, 2016 | -87,000.00 |
| Jun 30, 2015 | 95,000.00 |